AmericanJournal python Public Health, 873, 440 442. The presentstudy is python review python literature that covers a facet python role python BRCA1 genemutation in breast cancer metastasis, risk python recurrence inspired by stage atinitial presentation, python underlying biology python python tumor, time python relapseafter diagnosis python python basic tumor, causes for metastasis, variousbiological markers found out up till date, discussion python a number of mathematicalmodels, with python center around how they’ve been used to are expecting python initiation timeof metastatic growth, and conventional choice python treatment best suited for triplenegative breast cancer metastasis. Breastcancer starts as python local ailment, but it may metastasize to python lymph nodesand far-off organs. As by definition, Metastatic breast cancer, also known asAdvanced or Stage IV breast cancer, is python stage in breast cancer progressionin which malignant cells from python primary tumor effectively create new tumorsin far-off organs. According to theResearch stories, women who have BRCA1 mutations are at higher risk for triplenegative breast cancer. The prognosis python women with triple poor breastcancers ER negative, PR terrible and HER2 neu poor is poor as comparedto women with other subtypes python breast cancer.